MLTX Earnings

Quarterly EPS
$-0.56
Q3 2024
$-0.70
Q4 2024
$-0.63
Q1 2025
$-0.87
Q2 2025
$-1.10
Q3 2025
$-0.88
Q4 2025
$-0.98
Q1 2026
$-0.84
Q2 2026
Latest RevenueN/A
Latest Net Income-61805000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.840-61805000+3.4%
Q1 2026-$0.980-69707000-55.6%
Q4 2025-$0.880-63018000-25.7%
Q3 2025-$1.100-70694000-96.4%
Q2 2025-$0.870-56051000-123.1%
Q1 2025-$0.630-40559000-186.4%
Q4 2024-$0.700-46395000-483.3%
Q3 2024-$0.560-36114000-211.1%
Q2 2024-$0.390-24759000
Q1 2024-$0.220-13975000
Q4 2023-$0.120-7887390
Q3 2023-$0.180-11619353
MoonLake Immunotherapeutics (MLTX) — Earnings